Akebia Therapeutics (AKBA)'s 30-day implied volatility (IV30) was 92.8% at the close on November 11, 2026, up from 71.6% the day before, against a 52-week range of 45.6% to 132.5%. Its 20-day historical volatility was 100.1%.
Data as of November 11, 2026.